Last reviewed · How we verify
Sintamil (nitroxazepine)
Sintamil (generic name: nitroxazepine) is a nitroxazepine drug. It is currently in unknown development.
Sintamil works by interacting with a specific target in the body, although its exact mechanism is not well understood.
Nitroxazepine is a tricyclic antidepressant introduced in 1982 for the treatment of depression and nocturnal enuresis. It acts as a serotonin-norepinephrine reuptake inhibitor, similar to imipramine but with lower anticholinergic side effects.
At a glance
| Generic name | nitroxazepine |
|---|---|
| Drug class | nitroxazepine |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells have locks on them, and Sintamil has a key that fits into one of those locks. When it binds to the lock, it can affect how the cell works, but we don't know exactly how it does that yet. This is a simplified way of thinking about how Sintamil might work, but more research is needed to understand its full effects.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sintamil CI brief — competitive landscape report
- Sintamil updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Sintamil
What is Sintamil?
How does Sintamil work?
What is the generic name of Sintamil?
What drug class is Sintamil in?
What development phase is Sintamil in?
Related
- Drug class: All nitroxazepine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing